Loss of DGK  induces endothelial cell activation and death independently of complement activation

Complement Mutations in Diacylglycerol Kinase- -Associated Atypical Hemolytic Uremic Syndrome

(2014) D. Sanchez Chinchilla et al.   Clinical Journal of the American Society of Nephrology

Phenotypic Expansion of DGKE-Associated Diseases

(2014) R. Westland et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome

(2013) M. Frimat et al.   BLOOD

Genetics and Outcome of Atypical Hemolytic Uremic Syndrome: A Nationwide French Series Comparing Children and Adults

(2013) V. Fremeaux-Bacchi et al.   Clinical Journal of the American Society of Nephrology

Atypical hemolytic uremic syndrome: From the rediscovery of complement to targeted therapy

(2013) Fadi Fakhouri et al.   European Journal of Internal Medicine

Cyclosporine Induces Endothelial Cell Release of Complement-Activating Microparticles

(2013) B. Renner et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

DGKE and atypical HUS

(2013) Susan E Quaggin   NATURE GENETICS

Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome

(2013) Mathieu Lemaire et al.   NATURE GENETICS

A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function

(2012) L. T. Roumenina et al.   BLOOD

DGKE Variants Cause a Glomerular Microangiopathy That Mimics Membranoproliferative GN

(2012) F. Ozaltin et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies

(2012) Julien Zuber et al.   Nature Reviews Nephrology

Regulation and Functions of Diacylglycerol Kinases

(2011) Yulia V. Shulga et al.   CHEMICAL REVIEWS

Substrate specificity of diacylglycerol kinase-epsilon and the phosphatidylinositol cycle

(2011) Yulia V. Shulga et al.   FEBS LETTERS

Alternative complement pathway assessment in patients with atypical HUS

(2011) Lubka T. Roumenina et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Atypical hemolytic uremic syndrome

(2011) Chantal Loirat et al.   Orphanet Journal of Rare Diseases

Advances in understanding the aetiology of atypical Haemolytic Uraemic Syndrome

(2010) Pilar Sánchez-Corral et al.   BRITISH JOURNAL OF HAEMATOLOGY

Pregnancy-Associated Hemolytic Uremic Syndrome Revisited in the Era of Complement Gene Mutations

(2010) F. Fakhouri et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Genetics and complement in atypical HUS

(2010) David Kavanagh et al.   PEDIATRIC NEPHROLOGY

Thrombomodulin Mutations in Atypical Hemolytic–Uremic Syndrome

(2009) Mieke Delvaeye et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome

(2008) V. Fremeaux-Bacchi et al.   BLOOD

MSK activation and physiological roles

(2008) J. Simon et al.   Frontiers in Bioscience-Landmark

Protein kinase C-δ mediates von Willebrand factor secretion from endothelial cells in response to vascular endothelial growth factor (VEGF) but not histamine

(2008) O. LORENZI et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

VEGF Inhibition and Renal Thrombotic Microangiopathy

(2008) Vera Eremina et al.   NEW ENGLAND JOURNAL OF MEDICINE